Alta Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-23,198
| Closed | -$1.29M | – | 103 |
|
|
2025
Q3 | $1.29M | Sell |
23,198
-284,519
| -92% | -$16.7M | 0.07% | 65 |
|
|
2025
Q2 | $21.2M | Buy |
307,717
+19,130
| +7% | +$1.3M | 1.21% | 29 |
|
|
2025
Q1 | $20M | Buy |
288,587
+84,358
| +41% | +$6.97M | 1.3% | 28 |
|
|
2024
Q4 | $17.6M | Sell |
204,229
-602
| -0.3% | -$65.1K | 1.05% | 30 |
|
|
2024
Q3 | $24.4M | Buy |
204,831
+94,919
| +86% | +$12.7M | 1.45% | 28 |
|
|
2024
Q2 | $15.7M | Buy |
+109,912
| New | +$14.6M | 0.99% | 33 |
|
|
2019
Q3 | – | Sell |
-14,572
| Closed | -$371K | – | 100 |
|
|
2019
Q2 | $371K | Sell |
14,572
-20,906
| -59% | -$517K | 0.02% | 71 |
|
|
2019
Q1 | $927K | Sell |
35,478
-1,686,672
| -98% | -$41.5M | 0.05% | 59 |
|
|
2018
Q4 | $39.7M | Sell |
1,722,150
-16,144
| -0.9% | -$359K | 2.57% | 16 |
|
|
2018
Q3 | $41M | Buy |
1,738,294
+55,926
| +3% | +$1.36M | 2.27% | 21 |
|
|
2018
Q2 | $38.8M | Sell |
1,682,368
-2,260
| -0.1% | -$53.7K | 2.39% | 18 |
|
|
2018
Q1 | $41.5M | Sell |
1,684,628
-18,584
| -1% | -$488K | 2.58% | 19 |
|
|
2017
Q4 | $45.7M | Sell |
1,703,212
-26,568
| -2% | -$676K | 2.88% | 16 |
|
|
2017
Q3 | $41.6M | Sell |
1,729,780
-34,686
| -2% | -$784K | 2.69% | 17 |
|
|
2017
Q2 | $37.8M | Sell |
1,764,466
-80,258
| -4% | -$1.62M | 2.56% | 20 |
|
|
2017
Q1 | $31.6M | Buy |
1,844,724
+185,018
| +11% | +$3.22M | 2.12% | 24 |
|
|
2016
Q4 | $29.8M | Sell |
1,659,706
-160,538
| -9% | -$2.91M | 2.13% | 23 |
|
|
2016
Q3 | $37.9M | Buy |
1,820,244
+20,298
| +1% | +$503K | 2.36% | 22 |
|
|
2016
Q2 | $48.4M | Buy |
1,799,946
+32,446
| +2% | +$890K | 2.99% | 11 |
|
|
2016
Q1 | $47.9M | Buy |
1,767,500
+394,292
| +29% | +$10.6M | 2.95% | 14 |
|
|
2015
Q4 | $39.9M | Buy |
1,373,208
+50,850
| +4% | +$1.41M | 3.22% | 8 |
|
|
2015
Q3 | $35.9M | Buy |
1,322,358
+8,864
| +0.7% | +$251K | 3.05% | 11 |
|
|
2015
Q2 | $36M | Buy |
1,313,494
+11,250
| +0.9% | +$316K | 2.95% | 8 |
|
|
2015
Q1 | $34.8M | Sell |
1,302,244
-725,464
| -36% | -$16.7M | 2.96% | 8 |
|
|
2014
Q4 | $42.9M | Buy |
2,027,708
+50,940
| +3% | +$1.14M | 3.58% | 3 |
|
|
2014
Q3 | $47.1M | Sell |
1,976,768
-20,534
| -1% | -$473K | 4.36% | 2 |
|
|
2014
Q2 | $46.1M | Buy |
1,997,302
+28,240
| +1% | +$623K | 4.25% | 2 |
|
|
2014
Q1 | $44.9M | Buy |
1,969,062
+58,022
| +3% | +$1.24M | 4.35% | 2 |
|
|
2013
Q4 | $35.3M | Buy |
1,911,040
+102,400
| +6% | +$1.78M | 3.62% | 3 |
|
|
2013
Q3 | $30.6M | Buy |
1,808,640
+71,460
| +4% | +$1.2M | 3.68% | 3 |
|
|
2013
Q2 | $26.9M | Buy |
+1,737,180
| New | +$28.9M | 3.64% | 3 |
|
Other funds holding NVO
F
Alta Capital Management's NVO Position: Q4 2025 in Review
Alta Capital Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 23,198 shares — an estimated $1.29M sold.
Alta Capital Management first reported a position in NVO in Q2 2013 and held it in 31 quarters. The position peaked at $48.4M in Q2 2016. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- Alta Capital Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- Alta Capital Management sold 23,198 Novo Nordisk shares in Q4 2025, an estimated $1.29M.
- Alta Capital Management first reported a position in Novo Nordisk in Q2 2013 and held it in 31 quarters.
- Alta Capital Management's Novo Nordisk position peaked at $48.4M in Q2 2016.
- 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on Alta Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.